The role of cytoskeletal proteins in cardiomyopathies

https://doi.org/10.1016/S0955-0674(98)80096-3Get rights and content

Abstract

Cardiomyopathies are serious heart muscle disorders in children and adults, which result in morbidity and premature death. These disorders include hypertrophic cardiomyopathy, dilated cardiomyopathy and restrictive cardiomyopathy. Recently, mutations in seven genes, all encoding sarcomeric proteins, have been identified as causes of familial hypertrophic cardiomyopathy. The gene include those encoding the β-myosin heavy chain, α-tropomyosin, cardiac troponin T, myosin binding protein-C, myosin essential light chain, myosin regulatory light chain, and troponin I. Advances in the understanding of dilated cardiomyopathy have been made recently as well and it appears as if cytoskeletal proteins play a central role. Dystrophin has been identified as the gene responsible for X-linked dilated cardiomyopathy and this protein, which is also responsible for Duchenne and Becker muscular dystrophy, plays an important role in myocyte and cardiomyocyte function. Mutations in order cytoskeletal proteins such as metavinculin, α-dystroglycan, α- and γ-sarcoglycan, and muscle LIM protein have also been found to result in dilated cardiomyopathy, suggesting that cytoskeletal proteins play a central role in cardiac function.

References (67)

  • A Kimura et al.

    Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

    Nat Genet

    (1997)
  • C MacRae et al.

    Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3

    J Clin Invest

    (1995)
  • H Watkins et al.

    Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy

    N Engl J Med

    (1995)
  • H Watkins et al.

    Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

    N Engl J Med

    (1992)
  • A Geisterfer-Lowrance et al.

    A mouse model of familial hypertrophic cardiomyopathy

    Science

    (1996)
  • H Sweeney et al.

    Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction

    J Biol Chem

    (1994)
  • EB Lankford et al.

    Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

    J Clin Invest

    (1995)
  • D Lin et al.

    Altered cardiac troponin T in vitro function in the presence of a mutation implication in familial hypertrophic cardiomyopathy

    J Clin Invest

    (1996)
  • M Gautel et al.

    Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?

    EMBO J

    (1995)
  • CS Farah et al.

    The troponin complex and regulation of muscle contraction

    FASEB J

    (1995)
  • PJ Keeling et al.

    Familial dilated cardiomyopathy in the United Kingdom

    Br Heart J

    (1995)
  • R Ohlendieck

    Towards an understanding of the dystrophinglycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers

    Eur J Cell Biol

    (1996)
  • RD Bies et al.

    A 5′ dystrophin duplication mutation causes membrane deficiency of α-dystroglycan in a family with X-linked cardiomyopathy

    Am J Hum Genet

    (1997)
  • V Nigro et al.

    Identification of the Syrian Hamster cardiomyopathy gene

    Hum Mol Genet

    (1997)
  • GF Cox et al.

    Dystrophies and heart disease

    Curr Opin Cardiol

    (1997)
  • M Maeda et al.

    Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin

    Circulation

    (1997)
  • KR Bowles et al.

    Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21–23

    J Clin Invest

    (1996)
  • M Koenig et al.

    Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

    Cell

    (1987)
  • R Klietsch et al.

    Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle

    Circ Res

    (1993)
  • AH Ahn et al.

    The structure and functional diversity of dystrophin

    Nat Genet

    (1993)
  • AP Koenig Monaco et al.

    The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein

    Cell

    (1988)
  • TJ Byers et al.

    Sequence similarity of the amino-terminal domain of Drosophila beta-spectrin to alpha-actinin and dystrophin

    J Cell Biol

    (1989)
  • M Koenig et al.

    Dilated analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility

    J Biol Chem

    (1990)
  • Cited by (240)

    • Myopathic Cardiac Genotypes Increase Risk for Myocarditis

      2021, JACC: Basic to Translational Science
    • Quantitative proteomic analysis reveals high interference on protein expression of H9c2 cells activated with glucose and cardiotonic steroids

      2020, Journal of Proteomics
      Citation Excerpt :

      In both H9c2 and HEK 293 cells, the expression of proteins related to protein folding was decreased. Hundreds of publications have reported the alteration of cytoskeletal proteins induced by natural cellular processes [49], hormone activation [50], microorganism infection [51], drugs [52] and cardiomyopathies [53,54]. The expression of actin and tubulin, the main protein constituents of microfilaments and microtubules, respectively, along with dozens of their respective known binding proteins was quantitatively altered after induction with CTSs and glucose in the present work.

    • Cardiovascular physiology for intensivists

      2018, Critical Heart Disease in Infants and Children
    View all citing articles on Scopus
    View full text